The evolution of prostacyclins in pulmonary arterial hypertension: from classical treatment to modern management (original) (raw)
Prostacyclin Use Among Patients with Pulmonary Arterial Hypertension in the United States: A Retrospective Analysis of a Large Health Care Claims Database
Charles D Burger
Journal of managed care & specialty pharmacy, 2017
View PDFchevron_right
Oral Prostacyclin Therapy for Pulmonary Arterial Hypertension : Another Step Forward
Aaron Waxman
View PDFchevron_right
Transition from Prostacyclin Analogue Infusion to Oral Therapy in Patients with Pulmonary Arterial Hypertension: A Five Year Follow-Up
Tahir Jameel
Journal of the American College of Cardiology, 2013
View PDFchevron_right
Transition from prostacyclin analogue infusion to oral therapy in patients with pulmonary arterial hypertension: a 5-year follow-up
Tahir Ahmed
Pulmonary circulation, 2013
View PDFchevron_right
Role of prostacyclin in pulmonary hypertension
Nura Mohamed
Global Cardiology Science and Practice, 2014
View PDFchevron_right
Adverse Events of Prostacyclin Mimetics in Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis
Mohammad Eddama
Journal of Clinical Medicine
View PDFchevron_right
Diverse Pharmacology of Prostacyclin Mimetics: Implications for Pulmonary Hypertension
Lucie Clapp
Molecular Mechanism of Congenital Heart Disease and Pulmonary Hypertension, 2020
View PDFchevron_right
Prostacyclin Administration Errors in Pulmonary Arterial Hypertension Patients Admitted to Hospitals in the United States: A National Survey
Martha Kingman
CHEST Journal, 2009
View PDFchevron_right
Practical considerations for therapies targeting the prostacyclin pathway
Wendy Gin-Sing
European Respiratory Review, 2016
View PDFchevron_right
Prostacyclin and its analogues in the treatment of pulmonary hypertension
Andrea Olschewski, Werner Seeger
Pharmacology & Therapeutics, 2004
View PDFchevron_right
Saudi experience in the management of pulmonary arterial hypertension; The outcome of PAH therapy with the exclusion of chronic parenteral prostacyclin
Enas Batubara
Annals of Thoracic Medicine
View PDFchevron_right
Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin (epoprostenol)
W. Tomkowski
Annals of Internal …, 1990
View PDFchevron_right
Treatment of pulmonary hypertension with the continuous infusion of a prostacyclin analogue, iloprost
George Cremona
Heart (British Cardiac Society), 1998
View PDFchevron_right
Cost Effectiveness of Prostacyclins in Pulmonary Arterial Hypertension
Antonio Román
Applied Health Economics and Health Policy, 2012
View PDFchevron_right
Prostacyclin and Iloprost in the Treatment of Primary Pulmonary Hypertension
Christopher McCabe
View PDFchevron_right
Long term treatment of pulmonary arterial hypertension with beraprost, an oral prostacyclin analogue
Sergio Morelli
Heart (British Cardiac Society), 2001
View PDFchevron_right
Current Pharmacological Treatment of Pulmonary Arterial Hypertension
Paschalis Steiropoulos
Current Clinical Pharmacology, 2008
View PDFchevron_right
Management Of Pulmonary Arterial Hypertension: A Brief Overview
Shatavisa Mukherjee
2017
View PDFchevron_right
A multicenter, retrospective study of patients with pulmonary arterial hypertension transitioned from parenteral prostacyclin therapy to inhaled iloprost
Roxana Sulica
Pulmonary Circulation, 2013
View PDFchevron_right
Long-Term Prostacyclin for Pulmonary Hypertension With Associated Congenital Heart Defects
Rafal Nizankowski
Circulation, 1999
View PDFchevron_right
Selexipag: an oral, selective prostacyclin receptor agonist for the treatment of pulmonary arterial hypertension
Marcin Kurzyna
European Respiratory Journal, 2012
View PDFchevron_right
Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled trial
Meinhard Kneussl
Journal of the American College of Cardiology, 2002
View PDFchevron_right
Impact of Parenteral Prostanoids in Pulmonary Arterial Hypertension: The Relevance of Timing
Michela Boromei
Journal of Clinical Medicine
View PDFchevron_right
Transition From Prostacyclin to Bosentan in Five Patients With Severe Pulmonary Hypertension: the Switch Is Possible
Miguel Sanchez
Revista Espanola De Cardiologia, 2006
View PDFchevron_right
Efficiency of Prostacyclin in the Treatment of Protamine-Mediated Right Ventricular Failure and Acute Pulmonary Hypertension
Ilker Kiris
The Tohoku Journal of Experimental Medicine, 2005
View PDFchevron_right
Evidence for the use of combination targeted therapeutic approaches for the management of pulmonary arterial hypertension
Dermot O'Callaghan
Respiratory Medicine, 2010
View PDFchevron_right
Conversion to Bosentan From Prostacyclin Infusion Therapy in Pulmonary Arterial Hypertension *
H. Farber
CHEST Journal, 2006
View PDFchevron_right
Combination therapy of prostacyclin for pulmonary hypertension in congenital heart disease
Decho Jakrapanichakul
Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2005
View PDFchevron_right
Clinical and cost effectiveness of treatments for pulmonary arterial hypertension (PAH) within their licensed indications
Sue Jowett
View PDFchevron_right
New Insights in the Treatment Strategy for Pulmonary Arterial Hypertension
Ryozo Nagai
Cardiovascular Drugs and Therapy, 2006
View PDFchevron_right
A review of pulmonary arterial hypertension: Part 2: Current and expected treatments
Pieter E Postmus
View PDFchevron_right
Key Articles and Guidelines in the Management of Pulmonary Arterial Hypertension: 2011 Update
Tyree Kiser
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2012
View PDFchevron_right